The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus

Endometrial cancer is becoming an increasing problem. Taking into account its pathomechanisms, we aimed to investigate whether FGF 21, an important metabolism regulator, could be used as a biomarker for endometrial cancer. The study included 233 patients who were classified into five subgroups depen...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagodzińska, Anna, Chudecka-Głaz, Anita, Michalczyk, Kaja, Pius-Sadowska, Ewa, Wieder-Huszla, Sylwia, Jurczak, Anna, Machaliński, Bogusław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914808/
https://www.ncbi.nlm.nih.gov/pubmed/36766504
http://dx.doi.org/10.3390/diagnostics13030399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914808/
https://www.ncbi.nlm.nih.gov/pubmed/36766504
http://dx.doi.org/10.3390/diagnostics13030399

Ejemplares similares